altitude, the blood O2 equilibrium curve shifts progressively leftward because of respiratory alkalosis. This left shift protects arterial O2 saturation at extreme altitude. high altitude; acid-base; oxygen affinity; hemoglobin; 2,3-diphosphoglycerate; hypoxia THE ERYTHROPOIETIC SYSTEM can participate in adaptation to high altitude in at least two ways: increased red cell number, and shifts in the position of the hemoglobin-02 equilibrium curve (OEC). The latter is controlled mainly by H+ (the Bohr effect) and 2,3-diphosphoglycerate (2,3-DPG). COz is an additional effector, but its physiologic importance under extreme conditions is less well defined.
A modest increase in the red cell mass is useful, physiologically, in increasing the 02 carrying capacity of the blood (6). However, recent speculation has cast doubt about the quantitative benefit from this mechanism. Since increasing hematocrit leads to an exponential increase in blood viscosity, systemic and pulmonary pressures and resistance to flow could be undesirable consequences (8).
Whether a shift to the right or left of the OEC could be beneficial in hypoxia is another dilemma needing experimental clarification.
Theoretical and animal studies (5, 22) suggest that a left shift would be beneficial at extreme altitude, but few data in humans are available. Although the OEC has been the subject of extensive experimental work at high altitude over the past half century, many of the results are of limited value because the effect of red cell 2,3-DPG concentration has been appreciated only recently (2, 4) . This compound has a profound effect on hemoglobin-O2 affinity, but since its concentration rapidly decreases in vitro, it must be measured within a few hours of blood collection. Obviously, immediate measurement is difficult in mountainous remote areas of the world.
The American Medical Research Expedition to Everest (AMREE, 1981) afforded a unique opportunity to study the red cell response and OEC at extreme altitude in 20 climbers and scientists. Our recent observations in the South American Andes indicated that sophisticated hematologic and acid-base measurements were possible, even under primitive circumstances (27) . In addition, we had recently developed new instruments for field use that made measurements of 2,3-DPG, P50 (the POT at which hemoglobin is 50% saturated), blood gases, and hematologic parameters possible, without the need to transport blood samples over long distances or time (15) (16) (17) (18) . This report summarizes the studies on Mt. Everest.
METHODS
Subjects. All AMREE members were males whose ages ranged from 26 to 52 yr old. The degree of physical training and climbing experience varied somewhat among the members of the group. Before the beginning of the expedition, all members were informed fully of the nature of the experiments and the risks of venipuncture; all consented to participate.
Laboratories and equipment. Studies were conducted in three principal locations: 1) San Diego, California (May 1981), 2) Base Camp (Sept 1981) , and 3) Camp II (middle and late Ott, 1981) . The locations and elevations of these sites are shown diagramatically in Fig. 1 . Care was taken to use the same techniques, instruments, and reagent stocks in each of the three locations. Instruments were packed and transported in special lightweight containers and carried at various times by ship, truck, plane, backpack, and yak. The laboratory huts and logistics of the expedition have been described by West (24). Blood gas and P50 measurements were not made at Base Camp because the pH meter and a tonometer unit were damaged; they were repaired only in time for the Camp II studies. Hematologic measurements.
All venous blood samples were taken without stasis using plastic syringes with no. 20 needles. The anticoagulant we used was heparin that contained enough NaF to provide a final blood concentration of about 1 pmol/ml. This concentration of NaF effectively inhibits glycolysis in whole blood (unpublished observations). The samples were immediately placed on ice where they were kept until use.
Hematocrit measurements were made using a batterypowered Compur Ml 100 minicentrifuge. This instrument has a radius of centrifugation of 3.46 cm and a speed of 11,500 rpm. Each centrifugation cycle was 3 min, 20 s. The samples were subjected to repeated centrifugation cycles until the reading was constant.
Total hemoglobin concentration was determined in two ways. In San Diego and at Base Camp, 20 ~1 of whole blood were added to 5 ml of Drabkin's solution (Fisher Scientific) containing 0.1% Sterox. After 20 min, the absorbance at 540 nm was determined with a PerkinElmer model 35 spectrophotometer. A standard curve was prepared using various dilutions of International Standard hemoglobin solution no. 90500 from the International Committee for Standardization in Hematology, World Health Organization, kindly supplied by Dr. 0. van Assendelft, Centers for Disease Control. Alternatively, hemoglobin concentration was measured using a WINSLOW, SAMAJA, AND WEST battery-powered Compur Ml000 miniphotometer and the reagents supplied by the manufacturer. No difference in results could be detected by the two methods. As a separate check of the hemoglobin measurements, 13 samples were drawn at Base Camp at the end of the expedition; hemoglobin concentration was measured and the samples were returned to Atlanta where the concentrations were measured using a Ljungberg hemometer.
Red blood cell counts were made with the Compur Ml000 miniphotometer and the reagent kits supplied by the manufacturer. The above instrument measures the turbidity of a cell suspension; no effort was made to verify its accuracy. Both of the Compur instruments have been evaluated previously (7).
2,3-DPG. Measurements of red cell 2,3-DPG were made using kits from Boehringer-Mannheim (catalog no. 148334). These kits were packed in dry ice and handcarried in insulated cartons to Katmandu and then by backpack to Base Camp. After the reagents were reconstituted, they were kept at ice temperature. The manufacturer's instruments for outdating the solutions were followed. Plastic disposable glassware was used throughout the procedures. Gilson micropipettors and tips were used to measure all reagents. Results are expressed as the [2,3-DPG]/[Hb] molar ratio. At sea level, Base Camp, and Camp II, protein-free extracts were made within minutes of venipuncture, according to the manufacturer's instructions. The extracts were neutralized and stored on ice. Control experiments at Base Camp confirmed that the extracts were stable for up to 5 days. Extracts made at Camp II were carried through the Khumbu icefall to Base Camp in a Dewar flask containing an ice-water slurry, usually on the day after preparation; the delay was never longer than 2 days. The 2,3-DPG assays were carried out at Base Camp on the day of receipt.
Blood gases and acid-base status. Blood gas and acidbase measurements were made at sea level and Camp II using the same instruments, electrodes, and standards. The instrument was an Instrumentation Laboratories (Lexington, MA) model 213 blood gas apparatus fitted with Instrumentation Laboratories POT, Pco~, and pH electrodes. Instrumentation Laboratories electrolytes and buffers were used throughout. Calibration mixtures of 02, C02, and N, were obtained from Lif-0-Gen (Cambridge, MD), and their compositions were specified to a nominal to.02 %.
Arterial blood was drawn at Camp II from radial arteries in three volunteers breathing either ambient air or a hypoxic mixture. The heparin-NaF anticoagulant described above was used, and the measurements were made immediately. Base excess was calculated using the algorithms of Thomas (21), modified to accept the O2 saturation values.
Tonometry flasks. Tonometry flasks were filled within 3 days of use; they were filled at Base Camp for measurements at Camp II. These flasks, described in detail elsewhere (16), were sealed with rubber injection stoppers. Two no. 25 needles were used to introduce the gas, which was flowing at 250 ml/min for 10 min. The outflow was connected to a length of tubing submerged in HZ0 to a level to insure that, at the end of the procedure, the pressure in the flask exceeded ambient pressure by 20 cmH20. Later, the pressures were equalized by allowing some gas to escape when injecting the blood.
RESULTS

Hemoglobin saturation.
We measured hemoglobin-02 saturation using an instrument constructed by Advanced Products (SRL, Milan, Italy) that is described separately (17). This consisted of a closed l-ml cuvette containing 0.01% sodium borate, pH 9.1, 0.1% Sterox, and a small amount of antifoaming agent in equilibrium with air. An O2 electrode with Instrumentation Laboratories electrolyte was in contact with the buffer. Lysis of the cells occurs when a sample of blood (10 ~1) is introduced into the buffer. Because of dilution and the very high pH, hemoglobin becomes saturated with 02, and the observed drop in Pas corresponds to the amount of deoxy hemoglobin present in the sample. After noting this drop, we added 5 ~1 K3Fe(CN)s to oxidize the hemoglobin and release all bound OZ. The rise in POT corresponds to total 0, capacity, and the ratio initial drop/total rise is fractional saturation. Figure 1 shows, diagramatically, the locations and altitudes of our various activities. The transportation of red cell extracts down the Khumbu icefall between Camp II and Base Camp was a continuous problem because of limited personnel and weather uncertainty.
Personal discomfort was considerable, particularly during the first 2 wk at Base Camp and the month at Camp II, but none of the operations or procedures was unreasonably difficult. Results of the programmed calculation of the saturation 0, and Pso results were extremely useful in monitoring results as data were taken. P,o measurements.
Blood PsO measurements were made according to the general method described previously (15). Oxygenated fresh blood (250 ~1) was injected into a tonometry flask that had been filled with gas mixtures of known O2 and CO2 composition to approximate the anticipated PFiO and arterial Pco~. The samples were equilibrated with the gases in a tonometer for 20 min at 37°C.
The tonometer was modified from that previously described (17); the heater block was removed from its housing and placed into a Styrofoam container for better insulation. The temperature of the blood was measured after each equilibration with a thermister probe (Yellow Springs Instrument, Yellow Springs, OH), kindly supplied by the manufacturer; it was specially calibrated by the factory before the expedition.
Hematocrit
and hemoglobin. Table 1 lists the values for hemoglobin, hematocrit, and mean corpuscular hemoglobin concentration at the various locations.
As expected, hematocrit and hemog!obin concentration increased over the period of exposure to altitude. Nevertheless, the hematocrit values were somewhat lower than those reported in previous studies at similar altitudes (3, 14) . In anticipation of such problems, our methods were standardized before and after the expedition. The hematocrit minicentrifuge, with battery power, was evaluated at the Centers for Disease Control with conventional methods and was found to be accurate. In addition, samples from Base Camp were returned to the United States, and measurements were made using conventional methods; these studies confirmed the accuracy of the method (Fig. 2) .
In general, persons whose hematocrits were in the lower part of the normal range at sea level remained in the lower range as altitude increased (Fig. 3) . No correlation between absolute hematocrit, or relative change, and performance in climbing or success in acclimitization was noted within the group.
Since the PO, is chosen close to Pso, a logarithmic form of the Hill equation
can be used to extrapolate to PsO. The slope, n = 2.62, corresponds to a 2,3-DPG/Hb ratio of 1.25 (16); slight variations in 2,3-DPG have little effect on this value (16). All of the calculations pertaining to saturation, PO*, Pco~, and Pso are discussed in detail in previous publications (16, 17) and were performed on a Texas Instruments SR-62 pocket calculator.
Mean corpuscular hemoglobin concentration.
Mean corpuscular hemoglobin concentration (MCHC) increased in all members (Fig. 4) . As with hematocrit, the increases were parallel and may reflect red cell dehydration, but other data related to hemoconcentration would be required to be certain.
Blood tonometry and acid-base status. Acid-base status was estimated or measured at several altitudes using the algorithms of Thomas (21); it was assumed that plasma protein changes did not affect the blood buffer base and that body temperature was 37°C in all cases. These algorithms allow consideration of the effect of hemoglobin saturation on the calculation of base excess. In all cases, our calculations were conducted using the measured saturation after tonometry. At sea level, the mean pH of equilibrated blood was 7.399 at PCO~ 41.9 Torr and hematocrit 43.8; this corresponds to a mean base excess of -0.3 meq/l, a value which is within the error of the methods. Since the same techniques were used throughout our work, comparisons should be valid. At Camp II, the mean base excess (n = 14) was -8.7 t 1.7 meq/l measured by tonometry. In three subjects, arterial blood was sampled and base excess was calculated from direct measurement of pH, Pco~, and saturation, and after tonometry of the same samples ( Table  2 ). The two methods gave similar results; base excess values were -6.7 meq/l for tonometry and -7.9 meq/l for the direct blood gas, pH, and saturation methods.
Blood drawn on the South Co1 from two subjects returning from the summit was subjected to the tonometry technique (Table 3) . Their mean in vitro base excess was -7.2 meq/l, a value close to the mean for the Camp II group as a whole. It appears that compensation for respiratory alkalosis for one of these subjects (CP) was less effective than it had been earlier. On Oct. 8, his base excess of Camp II was -9.8 meq/l, whereas on the day after reaching the summit (Ott 25) his base excess was -5.9 meq/l (Table 3) .
In vivo acid-base status on summit. Since direct sampling of arterial blood on the South Co1 or summit was not possible, in vivo pH must be inferred from the tonometry data. This was accomplished as follows. Venous blood was sampled from two climbers on the South Co1 (Table 3 ) about 12 h after returning from the summit. The samples were taken to Camp II and equilibrated to a final PCO~ of 22.6 Torr. The pH was measured, and BE was calculated using the Thomas algorithms (21). To estimate the summit pH, in one of the climbers (Table  4) we then used the alveolar PCO~ measured on the summit (7.5 Torr, Ref. 25) and assumed arterial PCO~ = alveolar Pco~. To construct an in vivo buffer line on the Sigaard-Anderson alignment nomogram (20), we reduced the hemoglobin concentration by one-third (19) and extrapolated to a summit pH of approximately 7.78.
Our figures predict that, for complete metabolic compensation on the summit, base excess would have to be about -18 meq/l (for blood pH of 7.4). Thus, blood pH is substantially higher than was predicted before the expedition (26). This has important consequences for the interpretation of 02 transport because of its effect on the OEC, as discussed below (DISCUSSION). &. Blood PFiO values at sea level and Camp II are given in Table 1 . The values have been adjusted to pH 7.4 using a Bohr factor of -0.45, corresponding to a 2,3-DPG/Hb ratio of 1.25 (18). As a check of these values, the P&s estimated from our previous work relating 2,3-DPG, pH, and PCO~ (28) are 28.3 Torr at sea level and 29.4 Torr at Camp II, compared with mean measured values of 28.1 and 29.8 Torr. Thus the P50 is completely accounted for by the known effecters of red cell oxygen affinity (2,3-DPG, pH, and Pco~); no additional factors need be postulated.
The PsO values for the South Co1 blood cannot be taken as representative of the group as a whole, because only two samples were studied. However, PsO increased in CP between Camp II and the South Col; 2,3-DPG also increased, whereas in pH, the difference was within the limits of the error found in sea level control experiments (to.08 mol/mol) (27).
Alveolar gas was measured on the summit in only one climber (CP). The data and calculations therefrom are given in Table 4 . To calculate the summit P50 in this subject, we used an in vivo blood pH of 7.78. The subjects PsO at pH 7.4 was 27.6 Torr; if the Bohr factor was -0.45, the PsO on the summit would have been 19.4 Torr. Table 5 and Fig. 5 summarize the P50 measurements. The PsO at pH 7.4 increases with increasing 2,3-DPG up to 6,300 m, but then decreases slightly, even though 2,3-DPG increases further. This may be explained by the lower PCO~ at which measurements were made at 6,300 m compared with sea level and the small number of observations above 6,300 m. However, a precise description of the effect of very low PCO~ on the whole blood OEC is still lacking (28).
DISCUSSION
Hemoglobin and hematocrit. Two previous expeditions to similar altitudes reported hematologic data in sufficient numbers to permit detailed comparisons (3, 14) ; this is shown in Table 6 . Using a t test for small samples, we found that our red cell counts at 6,300 m were not different from those in 1973. Our hemoglobin and hematocrit values were slightly different from those in 1960-61 (P = 0.025) but clearly different from those in 1973 (P c 0.005).
Of the measurements compared, hemoglobin concentration should be the simplest to verify. Unfortunately we were not given the details of the methods for blood collection or measurements in the previous studies. In the 1960-61 expedition, a subsample (n = 6) of subjects in whom red cell mass was measured had a mean hemoglobin concentration of 19.1 g/d1 (14). These data were from estimates of CO capacity, measured volumetrically. In 1973, the mean hemoglobin concentration for 10 sub- Values are means t SD for no. of measurements given in parentheses. See Tables 1 and 3 for definitions. jects at 5,350 m was 20.6 g/dl. These measurements were by the cyanomethemoglobin method, but the instruments, standards, and method of blood collection and storage were not given in the report (3) and some of the subjects had resided at altitudes greater than 5,000 m for extended periods of time (P. Cerretelli, personal communication).
Hematocrit, although more directly related to blood viscosity than hemoglobin concentration, is more difficult to measure accurately and even more difficult to verify. High hematocrits require longer centrifugation times and higher relative centrifugal fields (RCF). The National Committee for Clinical and Laboratory Standards (NCCLS) (14) defines the RCF RCF = 1.18 X 10D5 X r X n2 (2) where r is the rotating radius (cm) and n is the rotating speed (rpm). For our centrifuge, RCF = 5,400. According to Pugh (14) , their centrifuge had a radius of 10 cm and operated at 3,000 rpm; hence, RCF = 1,062. The centrifuge used in 1973 (3) operated at 3,500 rpm but the rotating radius is not given. In addition to these considerations, the NCCLS recommends that, when hematocrits are greater than 50%, RCF at the top of the blood column should be greater than 3,000. It is also essential to subject the samples to repeated centrifugations to verify that the hematocrit is minimal. It is possible, therefore, that neither of the two previous methods provided a sufficient centrifugal field to properly pack the cells.
Another suggestion that the 1973 hematocrits were too high comes from the distinctly low MCHC's found. Our data and those from 1960-61 agree quite well (35.2 g/d1 and 35.1 g/dl), whereas the 1973 data are unusually low (32.3 g/dl). Since the MCHC is the ratio of hemoglobin concentration to hematocrit, this seems best explained by a spuriously high hematocrit.
Mean corpuscular hemoglobin concentration. In spite of their concerted efforts to take in large amounts of liquid, MCHC increased in all expedition members. Since the flow properties of red cells are dependent, to some extent, on MCHC, understanding of this point could be of practical and theoretical importance. Unfortunately, we do not know whether red cell dehydration results from body dehydration or from some abnormality of red cell water transport. For example, it is known that 2,3-DPG influences the Donnan equilibrium of the red cell membrane to alter the relation between intracellular and extracellular pH (18). Changes in pH can affect red cell volume in vitro (29), but in vivo effects have not been demonstrated (1). This problem is in need of further study.
Hemoglobin saturation. A potential difficulty in the method at extreme altitude may be a lack of sufficient O2 dissolved in the borate buffer to completely oxygenate the hemoglobin when a sample is introduced; that this was not the case can be calculated as follows. If the cuvette volume is 1 ml, temperature is 25°C barometric pressure is 350 Torr, and the solubility of 0, in the borate buffer is 1.49 x 10m6 mol. 1-l l Torr-' (15), the total O2 in the cuvette would be 1.09 x low7 mol. If hemoglobin is half-saturated with 02 and its concentration is 20 g/ dl, 0.62 x 10m7 mol of O2 would be required for conversion of deoxy to oxyhemoglobin. Thus a twofold excess 02 was present; this is the worst case, because the hemoglobin concentration was usually less than 20 g/dl, and the temperature usually less than 25°C (thereby increasing O2 solubility). In fact, after addition of hemoglobin to the borate buffer, the mean Poft was 52.0 Torr (range 45.5 -58.3 Torr) for 21 determinations at Camp II. For the same 21 samples, the mean measured 02 saturation was 0.646 range 0.555 -0.736). Since hemoglobin can be assumed to be 100% saturated with 0, at a POT of 30 Torr in the borate buffer (15), our measurements are accurate, even at Camp II.
Blood 02 equilibrium curue. Shifts in the position and shape in the blood OEC have intrigued physiologists and biochemists for many years because of the implications for 0, transport and for adaptation to high altitude. Measurements made primarily in Andes of South America suggested that the OEC shifts to the right, thereby augmenting release of 02 to tissues (10). Most previous results, however, were made under standard conditions of pH and Pco~, and it has been appreciated only recently that, because of incomplete compensation for respiratory alkalosis, in vivo P,, up to 4,250 m is very close to that found at sea level (27) .
The importance of the red cell glycolytic intermediate, 2,3-DPG, was first appreciated in 1967 (2, 4). This compound has a strong influence on the oxygenation properties of hemoglobin; it shifts the OEC to the right, a potentially important mechanism for increasing O2 supply to tissues during anemia. The discovery was important for high altitude work, not only because of this effect on in the OEC, but also because it is quickly metabolized vitro and therefore must be measured in fresh blood samples. Much data from high altitude expeditions must be disregarded because 2,3-DPG was not measured or because samples were not studied while fresh.
A second problem with studies of the blood OEC at high altitude is that many measurements have been made under standard conditions; in vivo pH and PCO~ have usually not been considered. A P50 value at pH 7.4, PCO~ = 40 Torr has little relevance for a climber whose PCO* may be 7.5 Torr and pH nearly 7.8, as in the case of the present study. Before AMREE, no good data were available on arterial conditions at extreme altitude. The studies of Weiskopf and Severinghaus (23) also demonstrated a respiratory alkalosis, but they did not measure 2,3-DPG.
We have tried to measure all of the physiologic parameters of P.50. In a previous study, we measured P50 and 2,3-DPG in a large number of natives of the Peruvian Andes (27). These measurements, coupled with in vivo pH and Pco~, allowed us to conclude [as did Weiskopf and Severinghaus (23)] that a small right shift of the OEC, due to increased 2,3-DPG, is offset, in vivo, by a left shift, due to respiratory alkalosis. The net result was that in vivo P 50 was indistinguishable from sea-level controls.
Blood PH. We previously reported that polycythemia decreases the apparent blood pH at consta nt plasma pH (27 ). The mechanism of the effect is not understood, but we believe the most reliable pH would be that of plasma. However, existing nomograms and computer algorithms for blood acid-base and gas calculations use blood pH measured at unspecified hematocrits. Recognizing these limitations, we have reported blood pH values in Tables l-6. Any error introduced by hematocrit would, however, be small, since the hematocrits found in our subjects did not increase to the levels reported previously for Andean natives. For example, using formulas 2 and 3 of reference 27, the mean pH at Camp II of 7.413 would increase only 0.008 pH units if it were corrected to hematocrit 45%.
Z,3-DPG. Concentration of 2,3-DPG within the red cell is believed to be under the general control of pH (12). In our studies, pH increased strikingly above 6,300 m but with little additional increase in 2,3-DPG. Perhaps mean pH is not really increased; it may fall in exercise or during sleep. Acid-base balance. We found that respiratory alkalosis is never completely compensated. This finding is in agreement with previous observations in Andean natives at 4,250 m (11, 27) or in Sherpas at similar altitude (11). Sojourners also do not compensate, even after several weeks of acclimatization (11). This failure of blood pH to return to sea-level values is still not understood.
Estimations of in vivo base e xcess and, even more, arterial plasma pH, are subject to co nsiderable uncertainty arising from several sources. First, most nomograms are most accurate around normal conditions (21); the summit conditions are extreme. Second, the nomograms were constructed assuming blood and plasma pH are equivalent; polycythemia has not been accounted for. Third, the buffering effect of plasma has not been calculated in our studies. Increased MCHC suggests dehydration, which would increase plasma protein concentration. Finally, the in vivo ~H-Pco~ relationship is well known to differ from that found in vitro (19) .
In spite of the above limitations and qualifications, our data indicate that PsO is maintained over a very narrow range up to an altitude of 6,300 m. This maintenance is due to the opposing effects of 2,3-DPG and pH (the Bohr effect). Above 6,300 m, the OEC shifts progressively to the left, due to the stronger effect of alkalosis. The various effecters of the OEC are shown in summary in Fig. 5 . Although the estimates of in vivo pH are approximations, the clear rise above 6,300 m will certainly mean that arterial 02 saturation will be protected. Regardless of the mechanism of the extreme alkalosis, it Climbers does usua appear to be beneficial. lly elect to acclimatize for 1 or 2 days below the summit, then attempt the summit in sudden pushes. The progressive shift to the left of the OEC above Camp II suggests that this intuitive climbing strategy might be a good one; a left shift could confer some advantage because arterial saturation increases. Indeed, experimental animals survive better at extreme altitude when the OEC is left shifted (5), and persons with mutant hemoglobins with high 0, affinity apparently acclimatize more efficiently at moderate altitude than their normal counterparts (9). 
